Home » Topics » Regulatory » Patents

Patents
RSS

Recent patents describe novel antidiabetic agents

Nov. 28, 2008

Recent GSK patents disclose novel agents for tuberculosis

Nov. 27, 2008

New immunomodulatory agents disclosed in recent Novartis patent

Nov. 27, 2008

Novel PGE2 receptor modulators emerge from Astellas R&D

Nov. 27, 2008

Novel therapeutic agents for cancer cachexia and muscle wasting imparted in recent Santhera patent

Nov. 26, 2008

Recent GSK patent claims new 5-HT1A receptor antagonists for premature ejaculation

Nov. 26, 2008

Novel tachykinin NK1 receptor antagonists divulged in recent Merck & Co. patent

Nov. 26, 2008

Recent Daiichi Sankyo patent discloses novel antithrombotic agents

Nov. 25, 2008

New neuropsychiatric agents reported

Nov. 25, 2008

Novel therapeutic agents for cardiovascular disorders imparted in recent patent literature

Nov. 25, 2008

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...